Home > Chemicals & Materials > Specialty Chemicals > Custom Synthesis > Erdosteine Market
Erdosteine Market Size
- Report ID: GMI3371
- Published Date: May 2021
- Report Format: PDF
Erdosteine Market Size
Global Erdosteine Market size surpassed USD 105 million in 2020 and is likely to grow at a CAGR of 8.3% by 2027. The product is a molecule with free radical scavenging and mucolytic properties. Significant rise in the incidence of bronchitis primarily in the U.S., UK and Spain represents ample growth opportunities for erdosteine owing to its high effectiveness in reducing the symptoms of acute flareups in chronic bronchitis.
Growing focus on disease prevention rather than treatment and government prioritization towards healthcare funding has resulted in growing adoption of erdosteine by research institutes. The growing prevalence of adults with chronic diseases such as diabetes, obesity and heart disease has increased the requirement for therapeutic treatments which should drive the pharmaceutical research sector and augment the erdosteine market share.
| Report Attribute | Details |
|---|---|
| Base Year: | 2020 |
| Erdosteine Market Size in 2020: | 107.12 Million (USD) |
| Forecast Period: | 2021 to 2027 |
| Forecast Period 2021 to 2027 CAGR: | 8.3% |
| 2027 Value Projection: | 186.20 Million (USD) |
| Historical Data for: | 2016 to 2020 |
| No. of Pages: | 130 |
| Tables, Charts & Figures: | 188 |
| Segments covered: | End-Use, Application |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Erdosteine Market Scope
